The role of complement in nonalcoholic fatty liver disease

The role of complement in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver diseases globally. NAFLD includes a range of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis, cirrhosis or even hepatocellular carcinoma. Although...

Full description

Bibliographic Details
Main Authors:	Zhenya Guo, Xiude Fan, Jianni Yao, Stephen Tomlinson, Guandou Yuan, Songqing He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	complement system nonalcoholic fatty liver disease site-targeted inhibitor inflammation liver
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017467/full

Similar Items

Editorial: New insights into the role of complement system in liver diseases
by: Zhenya Guo, et al.
Published: (2023-09-01)

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
by: Zhenya Guo, et al.
Published: (2022-01-01)

Roles of the complement system in alcohol-induced liver disease
by: Yi Zhou, et al.
Published: (2020-10-01)

The role of the complosome in health and disease
by: Fang Xiao, et al.
Published: (2023-03-01)

Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
by: Guoqing Ouyang, et al.
Published: (2023-09-01)

Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study
by: Binbin Pan, et al.
Published: (2020-01-01)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
by: Ning Peng, et al.
Published: (2022-08-01)

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults
by: Yan Jiang, et al.
Published: (2012-01-01)

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults
by: Xin Ying, et al.
Published: (2012-01-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Nonalcoholic fatty liver disease: New epidemic
by: Rajkumar P Wadhwa, et al.
Published: (2021-01-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Nonalcoholic fatty liver disease and outcomes in patients with acute coronary syndrome
by: El-Saied Shaheen
Published: (2018-01-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Macrophage metabolism in nonalcoholic fatty liver disease
by: Wenhui Zhang, et al.
Published: (2023-10-01)

Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease
by: Alvina Alvina
Published: (2016-02-01)

Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease
by: Alvina
Published: (2009-12-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Byoung Kuk Jang
Published: (2012-12-01)

Analysis of the association between dietary patterns and nonalcoholic fatty liver disease in a county in Guangxi
by: Song Xiao, et al.
Published: (2023-09-01)

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
by: Hassan Pakravan, et al.
Published: (2017-01-01)

Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease
by: Shengnan Zhao, et al.
Published: (2023-12-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

Nonalcoholic Fatty Liver Disease and MicroRNAs: A Weighty Consideration
by: Sanjukta Mishra, et al.
Published: (2023-01-01)

Application of da Vinci surgery in hepatectomy
by: Shiliu Lu, et al.
Published: (2022-12-01)

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease
by: Mahsa Khodadoostan, et al.
Published: (2017-01-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)